Loading...
•
Mar 31, 2020
Protalix Q1 2020 Earnings Report
Reported financial results for the first quarter ended March 31, 2020, and provided a business update on recent corporate and clinical developments.
Key Takeaways
Protalix reports a transformational first quarter in 2020, closing a $43.7 million private placement and submitting a BLA for PRX-102 after completing the Phase III BRIDGE study.
Closed a $43.7 million private placement.
Completed Phase III BRIDGE study.
Submitted BLA for PRX-102.
Adapted quickly to the changing environment despite the COVID-19 pandemic.
Forward Guidance
Protalix is positioned for long-term success and looks forward to continuing momentum through the rest of this year and into 2021.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...